Tests in

JAK2 Exon 12 Mutation Analysis

View Test

JAK2 V617F Quantitative Mutation Analysis

View Test

JAK2 V617F Quantitative Mutation Analysis, with Reflex to Calreticulin

View Test

Joubert Syndrome Panel

  • Test Code:
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Brain malformations • Ciliopathies • Seizures/Epilepsy • Eye disorders • AHI1 • ARL13B • B9D1 • B9D2 • C5ORF42 • CC2D2A • CEP290 • CEP41 • INPP5E • KIF7 • MKS1 • NPHP1 • NPHP3 • OFD1 • RPGRIP1L • TCTN1 • TCTN2 • TMEM138 • TMEM216 • TMEM237 • TMEM67 • TTC21B
View Test
Innovations in Testing
View All Tests

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More